Correction | Published:


Nature Medicine volume 23, page 269 (2017) | Download Citation

In the January 2017 issue, the piece “Living therapeutics: Scientists genetically modify bacteria to deliver drugs” (Nat. Med 23, 5–7, 2017) incorrectly stated that the company Oragenics is slated to launch a phase 2 trial on ulcerative mucositis next year. In fact, they will begin the trial in 2017. The error has been corrected in the HTML and PDF versions of this article.

About this article

Publication history